| Document Date: 2006-11-27 18:11:14
Open Document File Size: 856,00 KBShare Result on Facebook
City Oakville / Mississauga / Jerusalem / Burlington / Montreal / Raleigh / Landis / Rayport / Spratt / Foster City / / Company Vector Laboratories / S.G. & Potter D.D. / Wang L.C. / GDNF / J. Comp / Alomone Laboratories / / Country United States / Canada / Israel / / Currency cent / / / IndustryTerm secretory machinery / trituration solution / pipette solution / treatment of Parkinson's disease / papain solution / presynaptic release machinery / postsynaptic site / extracellular bathing solution / / MedicalCondition Parkinson's disease / Parkinson disease / / MedicalTreatment gene therapy / / MusicAlbum Springer / / Organization Medical Research Council of Canada / EJLB / Federation of European Neuroscience Societies / Centre de Recherche / / Person Van Horne / Pixel / Nicole Leclerc / Louis-Eric Trudeau DeÂpartements de Pharmacologie / Fernand Seguin / Patrice Congar / Bourque / Frederick / / Position representative / / Product Midbrain injection / penicillin / Clozapine / Intrastriatal injection / / ProvinceOrState Quebec / S.K. / South Carolina / Ontario / / PublishedMedium Journal of Neuroscience / la Recherche / / Technology alpha / Neuroscience / antibodies / apoptosis / gene therapy / electrochemistry / /
SocialTag |
European Journal of Neuroscience, Vol. 12, pp. 3172±3180, 2000 Ó Federation of European Neuroscience Societies GDNF enhances the synaptic ef®cacy of dopaminergic neurons in culture